157 results
8-K
EX-99.1
YTEN
Yield10 Bioscience Inc
5 Mar 12
Metabolix Names Matthew Strobeck to Board of Directors
12:00am
manage our portfolio of technology and product offerings and to optimize the integration of our financial and business strategy.”
From June 2008 … of Metabolix products and technology, and optimizing the integration of our financial and business strategy, constitute forward-looking statements
S-1/A
YTEN
Yield10 Bioscience Inc
31 Aug 06
IPO registration (amended)
12:00am
a commercialization strategy for this
program, which would include the business plan for procuring commercial
quantities of switchgrass.
11 … strategy contemplates it entering into
collaborative arrangements with third parties for one or more of the
Company's programs. In the event
8-K
EX-99.1
YTEN
Yield10 Bioscience Inc
28 Mar 12
Metabolix Appoints Stephen J. Large to Board of Directors
12:00am
knowledge to the board,” said Richard P. Eno, President and CEO of Metabolix. “We look forward to Steve’s insight as we execute our business strategy … for commercialization of Metabolix products and technology, and executing our business strategy, constitute forward-looking statements. Such forward-looking statements
8-K
EX-99.1
YTEN
Yield10 Bioscience Inc
3 May 07
Entry into a Material Definitive Agreement
12:00am
of President and CEO,” commented Edward Muller, Chairman Emeritus of Metabolix. “Jay’s knowledge and experience of technology, strategy, and marketing … of growth strategies based on technology and marketing leadership. He has held executive positions in business management, marketing, strategy and technology
8-K
EX-99.1
pikpc7cy
23 Oct 19
Yield10 Bioscience Signs Research Agreement with J. R. Simplot
8:58am
FWP
hshmsrree
25 Oct 19
Free writing prospectus
12:49pm
8-K
EX-99.1
39u7bt 3v
11 Aug 20
Yield10 Bioscience Signs Research Agreement with GDM
8:42am
8-K
EX-99.1
w4hsh1
13 Feb 20
Yield10 Bioscience Appoints Agriculture Industry Veteran Sherri M. Brown, Ph.D., to Board of Directors
11:38am
8-K
EX-99.1
vhzao9796zav f40pxn
11 Aug 21
Yield10 Bioscience Announces Second Quarter 2021 Financial Results
4:05pm
424B4
mkb7go bfi6ezvk
20 Dec 17
Prospectus supplement with pricing info
12:00am
424B4
rjsuq pkq4h
18 Nov 19
Prospectus supplement with pricing info
12:00am
8-K
EX-99.1
rfndbc08hq799
12 Nov 19
Yield10 Bioscience Announces Third Quarter 2019 Financial Results
9:48am
424B4
wkdoe 59f
19 Oct 20
Prospectus supplement with pricing info
4:51pm
424B4
kt4y6 dodxcv7b74
3 Apr 20
Prospectus supplement with pricing info
10:36am